After 1 year of biologic therapy, admissions requiring noninvasive ventilation among patients with COPD and type 2 ...

For many years, treatment of asthma has focused on symptom management and control. As the understanding of disease processes has improved and treatments begin to target underlying mechanisms, there is ...

Due to chronic inflammation, those with COPD must learn to listen to what their bodies are telling them, writes columnist.

Receiving dupilumab for 52 weeks lowered the risk for severe exacerbations vs. placebo in adults with COPD and type 2 ...

Combined treatments for both aspects of obstructive sleep apnea (OSA)—a compromised airway anatomy and unstable ...

Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...

AMSTERDAM, Sept. 29, 2025 /PRNewswire/ -- Kaia Health, a global leader in digital therapeutics for chronic disease management, today announced a new collaboration with MedImprove, a leading private ...

For a long time, physicians and scientists believed our lungs were sterile (germ-free). But modern science indicates otherwise. Now we know they contain allergens, bacteria or viruses we inhale, such ...

Study did not meet primary endpoint in change from baseline in mean daily oral corticosteroid (OCS) dose at week 48, although clinical benefit for efzofitimod observed across multiple study parameters ...

Unfortunately, asthma and chronic obstructive pulmonary disease (COPD) are both underrecognized and underdiagnosed lung diseases. If they are properly identified, we have many opportunities to improve ...

May 23, 2025 -- The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD). It is the second biologic therapy approved for the condition, following the ...